These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 1330964

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Substitution of aromatic and nonaromatic amino acids for the Phe3 residue in the delta-selective opioid peptide deltorphin I: effects on binding affinity and selectivity.
    Heyl DL, Schmitter SJ, Bouzit H, Johnson TW, Hepp AM, Kurtz KR, Mousigian C.
    Int J Pept Protein Res; 1994 Nov; 44(5):420-6. PubMed ID: 7896499
    [Abstract] [Full Text] [Related]

  • 3. Cyclic dermorphin-like tetrapeptides with delta-opioid receptor selectivity. 3. Effect of residue 3 modification on in vitro opioid activity.
    Mosberg HI, Heyl DL, Haaseth RC, Omnaas JR, Medzihradsky F, Smith CB.
    Mol Pharmacol; 1990 Dec; 38(6):924-8. PubMed ID: 2174509
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Substitution on the Phe3 aromatic ring in cyclic delta opioid receptor-selective dermorphin/deltorphin tetrapeptide analogues: electronic and lipophilic requirements for receptor affinity.
    Heyl DL, Mosberg HI.
    J Med Chem; 1992 May 01; 35(9):1535-41. PubMed ID: 1315870
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Development of a model for the delta-opioid receptor pharmacophore: 3. Comparison of the cyclic tetrapeptide, Tyr-c[D-Cys-Phe-D-Pen]OH with other conformationally constrained delta-receptor selective ligands.
    Lomize AL, Pogozheva ID, Mosberg HI.
    Biopolymers; 1996 Feb 01; 38(2):221-34. PubMed ID: 8589255
    [Abstract] [Full Text] [Related]

  • 8. Dermenkephalin and deltorphin I reveal similarities within ligand-binding domains of mu- and delta-opioid receptors and an additional address subsite on the delta-receptor.
    Charpentier S, Sagan S, Delfour A, Nicolas P.
    Biochem Biophys Res Commun; 1991 Sep 30; 179(3):1161-8. PubMed ID: 1656944
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cyclic, disulfide- and dithioether-containing opioid tetrapeptides: development of a ligand with high delta opioid receptor selectivity and affinity.
    Mosberg HI, Omnaas JR, Medzihradsky F, Smith CB.
    Life Sci; 1988 Sep 30; 43(12):1013-20. PubMed ID: 2845204
    [Abstract] [Full Text] [Related]

  • 11. Binding to delta and mu opioid receptors by deltorphin I/II analogues modified at the Phe3 and Asp4/Glu4 side chains: a report of 32 new analogues and a QSAR study.
    Schullery SE, Mohammedshah T, Makhlouf H, Marks EL, Wilenkin BS, Escobar S, Mousigian C, Heyl DL.
    Bioorg Med Chem; 1997 Dec 30; 5(12):2221-34. PubMed ID: 9459020
    [Abstract] [Full Text] [Related]

  • 12. Effect of aromatic amino acid substitutions in the 3-position of cyclic beta-casomorphin analogues on mu-opioid agonist/delta-opioid antagonist properties.
    Schmidt R, Wilkes BC, Chung NN, Lemieux C, Schiller PW.
    Int J Pept Protein Res; 1996 Nov 30; 48(5):411-9. PubMed ID: 8956074
    [Abstract] [Full Text] [Related]

  • 13. Differential stereochemical requirements of mu vs. delta opioid receptors for ligand binding and signal transduction: development of a class of potent and highly delta-selective peptide antagonists.
    Schiller PW, Nguyen TM, Weltrowska G, Wilkes BC, Marsden BJ, Lemieux C, Chung NN.
    Proc Natl Acad Sci U S A; 1992 Dec 15; 89(24):11871-5. PubMed ID: 1334552
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Design and synthesis of 1-aminocycloalkane-1-carboxylic acid-substituted deltorphin analogues: unique delta and mu opioid activity in modified peptides.
    Breveglieri A, Guerrini R, Salvadori S, Bianchi C, Bryant SD, Attila M, Lazarus LH.
    J Med Chem; 1996 Feb 02; 39(3):773-80. PubMed ID: 8576920
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.